Economic evaluations of neglected tropical disease interventions in low- and middle-income countries: a systematic review protocol
JBI Evidence Synthesis · 2024
DOI: 10.11124/jbies-23-00339 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift JBI Evidence Synthesis, 2024. Verfasst von Biswajit Mahapatra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Public Health Research, Manbhum Ananda Ashram Nityananda Trust (MANT), Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Developing Countries, Neglected Diseases, Tropical Medicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Objective
The objective of this systematic review is to provide an overview of economic evaluation studies of interventions for neglected tropical diseases in low- and/or middle-income countries.
Introduction
The majority of people most susceptible to neglected tropical diseases reside in low- and middle-income countries and suffer significant economic impact due to these diseases. The World Health Organization suggests utilizing a systematic and cross-cutting approach with multiple interventions to lessen the neglected tropical disease burden. Inclusion criteria: Studies will be eligible for inclusion if they include economic evaluations of interventions for neglected tropical diseases and are conducted in low- and/or middle-income country settings.
Methods
A preliminary search of MEDLINE (PubMed) was undertaken using MeSH terms, such as neglected tropical disease, economic evaluation, therapeutics, low- and/or middle-income countries . Two reviewers will screen titles and abstracts independently, followed by a full-text review against the inclusion criteria. Disagreements will be resolved by discussion or with a third reviewer. To assess methodological quality, the JBI checklist for economic evaluations will be used. For economic evaluations, data will be extracted using the standardized JBI data extraction form. The Dominance Ranking Matrix will be used to summarize and compare the results of different types of economic evaluations. Cost per quality adjusted life year gained and cost per disability adjusted life year averted will be measures for economic evaluation. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used to assess the certainty of economic evidence, such as resource use and costs. Review registration: PROSPERO CRD42017070386
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Public Health Research, Manbhum Ananda Ashram Nityananda Trust (MANT), Kolkata, West Bengal, India.
- Evidence Synthesis and Implementation for Indigenous Health: A JBI Affiliated Group, Manbhum Ananda Ashram Nityananda Trust (MANT), Kolkata, West Bengal, India.
- State Institute of Health and Family Welfare, Department of Health and Family Welfare, Government of Himachal Pradesh, Shimla, Himachal Pradesh, India.
- Faculty of Life and Allied Health Sciences, M.S. Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India.
Zitieren
APA
Mahapatra, B., Mukherjee, N., Khatoon, S., Bhattacharya, P., Das, P., Bharti, O., & John, D. (2024). Economic evaluations of neglected tropical disease interventions in low- and middle-income countries: a systematic review protocol. JBI Evidence Synthesis. https://doi.org/10.11124/jbies-23-00339
Vancouver
Mahapatra B, Mukherjee N, Khatoon S, Bhattacharya P, Das P, Bharti O, et al. Economic evaluations of neglected tropical disease interventions in low- and middle-income countries: a systematic review protocol. JBI Evidence Synthesis. 2024. doi:10.11124/jbies-23-00339
BibTeX
@article{Mahapatra2024,
author = {Mahapatra, Biswajit and Mukherjee, Nirmalya and Khatoon, Sajda and Bhattacharya, Paramita and Das, Pritha and Bharti, Omesh and John, Denny},
title = {Economic evaluations of neglected tropical disease interventions in low- and middle-income countries: a systematic review protocol},
journal = {JBI Evidence Synthesis},
year = {2024},
doi = {10.11124/jbies-23-00339}
}
EUVIMED